Cancer-derived p53 mutants suppress p53-target gene expression--potential mechanism for gain of function of mutant p53
Open Access
- 1 March 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 35 (6), 2093-2104
- https://doi.org/10.1093/nar/gkm099
Abstract
Tumour-derived p53 mutants are thought to have acquired ‘gain-of-function’ properties that contribute to oncogenicity. We have tested the hypothesis that p53 mutants suppress p53-target gene expression, leading to enhanced cellular growth. Silencing of mutant p53 expression in several human cell lines was found to lead to the upregulation of wild-type p53-target genes such as p21, gadd45, PERP and PTEN. The expression of these genes was also suppressed in H1299-based isogenic cell lines expressing various hot-spot p53 mutants, and silencing of mutant p53, but not TAp73, abrogated the suppression. Consistently, these hot-spot p53 mutants were able to suppress a variety of p53-target gene promoters. Analysis using the proto-type p21 promoter construct indicated that the p53-binding sites are dispensable for mutant p53-mediated suppression. However, treatment with the histone deacetylase inhibitor trichostatin-A resulted in relief of mutant p53-mediated suppression, suggesting that mutant p53 may induce hypo-acetylation of target gene promoters leading to the suppressive effects. Finally, we show that stable down-regulation of mutant p53 expression resulted in reduced cellular colony growth in human cancer cells, which was found to be due to the induction of apoptosis. Together, the results demonstrate another mechanism through which p53 mutants could promote cellular growth.This publication has 38 references indexed in Scilit:
- Evaluation of the Combined Effect of p53 Codon 72 Polymorphism and Hotspot Mutations in Response to Anticancer DrugsClinical Cancer Research, 2005
- TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.2004
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.2000
- Surfing the p53 networkNature, 2000
- Cloning and characterization of the human BAG-1 gene promoter: upregulation by tumor-derived p53 mutantsOncogene, 1999
- Mutant p53: Gain-of-Function Oncoproteins and Wild-Type p53 InactivatorsBiological Chemistry, 1999
- Activation of c-myc Gene Expression by Tumor-Derived p53 Mutants Requires a Discrete C-Terminal DomainMolecular and Cellular Biology, 1998
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997